FLT3 inhibitors can overcome AML resistance to FLT3 inhibitors by inducing autophagy production through the AKT-mTORC1-ULK1 axis with the help of ATG3 (Koschade et al., 2022). This evidence concerns the gene ULK1 and acute myeloid leukemia.